Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mind Medicine (TSE:MMED)
NEO-L:MMED
Holding TSE:MMED?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 26, 2024 | Daniel Rollings Karlin Chief Medical Officer | xxxxxxxxxxxxx | $62491 |
| Mar 26, 2024 | Robert Barrow Chief Executive Officer | xxxxxxxxxxxxx | $156931 |
| Mar 26, 2024 | Schond L Greenway Chief Financial Officer | xxxxxxxxxxxxx | $54377 |
| Dec 26, 2023 | Daniel Rollings Karlin Chief Medical Officer | xxxxxxxxxxxxx | $24590 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Mind Medicine (TSE:MMED)?
Currently, no data Available
What percentage of Mind Medicine (TSE:MMED) stock is held by institutional investors?
Currently, no data Available
What percentage of Mind Medicine (TSE:MMED) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Mind Medicine (TSE:MMED)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.